Last Price Today's Change   Day's Range   Trading Volume
0.009   +0.001 (12.50%)  0.009 - 0.009  92,868


Avg Volume (4 weeks):348,158
4 Weeks Range:0.008 - 0.009
4 Weeks Price Volatility (%):
52 Weeks Range:0.008 - 0.023
52 Weeks Price Volatility (%):
Average Price Target:-


No recent Headlines for this stock.

Business Background

Alchemia Limited is a biotechnology company. The Company is engaged in the sale of its around the world intellectual property rights to Fondaparinum sodium, a generic anti-coagulant drug to Dr Reddy's Laboratories; closure of clinical trial activities, and review of new opportunities. The Company's segments include Fondaparinux and HyACT. The Company is engaged in the commercialization and improvements of its generic Fondaparinux product. The Company's HyACT is a platform technology that targets cancer drugs directly to tumors, designed to increase effectiveness against tumors without increasing toxicity. Its lead product candidate, HA-Irinotecan is used in the treatment of metastatic colorectal cancer (mCRC) and is in Phase III clinical trials. Its subsidiary, Alchemia Oncology Inc. is engaged in commercializing its HyACT and VAST platforms, including HA-Irinotecan. The Company's Audeo Oncology, Inc is engaged in the development and commercialization of the HyACT platform.

  Be the first to like this.


595  477  693  9392 

Top 10 Active Counters
 E2E 0.02+0.004 
 AUZ 0.0440.00 
 BSM 0.015+0.002 
 SRO 0.0020.00 
 JAT 0.091+0.011 
 VEC 0.023-0.002 
 CDX 0.047-0.001 
 WSI 0.021+0.005 
 IAM 0.009-0.001 
 MDI 0.0060.00 
Partners & Brokers